Research Paper Volume 11, Issue 24 pp 12295—12314
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
Figure 7. ERK1 and ERK2 expression were associated with distinct prognostic features of breast cancer. (A–C) Kaplan-Meier Plotter analysis indicated that high expression of ERK1 was associated with prolonged OS, recurrence and DMFS in patients with breast cancer. (D) Kaplan-Meier Plotter analysis indicated that high expression of ERK1 was associated with prolonged OS in patients receiving endocrine therapy. (E–G) Kaplan-Meier Plotter analysis showed that the high expression of ERK2 was associated with poor OS, recurrence and DMFS in patients with breast cancer. (H) Kaplan-Meier Plotter analysis indicated that high expression of ERK2 was not associated with OS in patients receiving endocrine therapy.